🇺🇸 FDA
Patent

US 8383633

Aminopyrimidines useful as kinase inhibitors

granted A61PA61P1/04A61P1/16

Quick answer

US patent 8383633 (Aminopyrimidines useful as kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61P, A61P1/04, A61P1/16, A61P1/18, A61P11/00